Health Care: Drugs

Nektar Therapeutics Inc (NKTR: NASDAQ)

$14.64 -0.42 | -2.79%
01/30/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 15.06
52 Week High 17.53
52 Week Low 10.10
Avg. Daily Vol. (Mil) 1.06
Beta (3 year) 1.76
Share Related Items
Mkt Cap (Mil) 1,934.33
Shares Out (Mil) 128.44
Float (Mil) 102.52
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.50
Current Ratio 4.00
LT Debt/ Equity 2.76
Total Debt / Equity 2.76
Valuation Ratios
Price Earnings n.a.
Price/Sales 9.11
Price/Book 40.97
Price/Cash Flow -45.20
Per Share Data
Earnings -0.51
Sales 1.65
Book Value 0.37
Cash Flow -0.33
Business Summary
Nektar Therapeutics, Inc., is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients.
General Information
455 Mission Bay Boulevard So
San Francisco, CA 94158
Industry : Drugs
Sector: Health Care
Employees: 445
CEO: Mr. Howard W. Robin
Short Interest
Current Month (Mil) 9.43
Previous Month (Mil) 8.90
Short Interest Ratio (Days) 11.00
Management Effectiveness
Return on Equity n.a.
Return on Assets -11.70
Return on Investments -31.50
Gross Margin 91.50
EBIT Margin -6.70
Profit Margin -26.30

Portfolios with NKTR

Latest NKTR Headlines from TheStreet

More Financial News for NKTR

Press Releases for NKTR

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter